NO924290D0 - Azabenzimidazoler for behandling av astma, artritt og lignende lidelser - Google Patents

Azabenzimidazoler for behandling av astma, artritt og lignende lidelser

Info

Publication number
NO924290D0
NO924290D0 NO924290A NO924290A NO924290D0 NO 924290 D0 NO924290 D0 NO 924290D0 NO 924290 A NO924290 A NO 924290A NO 924290 A NO924290 A NO 924290A NO 924290 D0 NO924290 D0 NO 924290D0
Authority
NO
Norway
Prior art keywords
arthrites
astma
azabenzimidazoles
treatment
similar disorders
Prior art date
Application number
NO924290A
Other languages
English (en)
Norwegian (no)
Other versions
NO924290L (no
Inventor
Anthony Marfat
James Frederick Eggler
Kelvin Cooper
Michael Jonathan Fray
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO924290D0 publication Critical patent/NO924290D0/no
Publication of NO924290L publication Critical patent/NO924290L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO92924290A 1990-05-09 1992-11-06 Azabenzimidazoler for behandling av astma, artritt og lignende lidelser NO924290L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52119990A 1990-05-09 1990-05-09
PCT/US1991/002997 WO1991017163A1 (en) 1990-05-09 1991-05-01 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY

Publications (2)

Publication Number Publication Date
NO924290D0 true NO924290D0 (no) 1992-11-06
NO924290L NO924290L (no) 1992-11-06

Family

ID=24075786

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924290A NO924290L (no) 1990-05-09 1992-11-06 Azabenzimidazoler for behandling av astma, artritt og lignende lidelser

Country Status (28)

Country Link
EP (1) EP0533695B1 (en, 2012)
JP (1) JPH0678340B2 (en, 2012)
CN (1) CN1057839A (en, 2012)
AP (1) AP224A (en, 2012)
AT (1) ATE112567T1 (en, 2012)
AU (1) AU642265B2 (en, 2012)
BG (1) BG97059A (en, 2012)
BR (1) BR9106433A (en, 2012)
CA (1) CA2080476A1 (en, 2012)
DE (1) DE69104481T2 (en, 2012)
DK (1) DK0533695T3 (en, 2012)
ES (1) ES2061247T3 (en, 2012)
FI (1) FI925053L (en, 2012)
GT (1) GT199100031A (en, 2012)
HU (1) HUT62894A (en, 2012)
IE (1) IE911553A1 (en, 2012)
IL (1) IL98075A0 (en, 2012)
MA (1) MA22151A1 (en, 2012)
MY (1) MY105512A (en, 2012)
NO (1) NO924290L (en, 2012)
NZ (1) NZ238089A (en, 2012)
PE (1) PE26691A1 (en, 2012)
PT (1) PT97616A (en, 2012)
RO (1) RO109450B1 (en, 2012)
TW (1) TW205549B (en, 2012)
WO (1) WO1991017163A1 (en, 2012)
YU (1) YU81191A (en, 2012)
ZA (1) ZA913497B (en, 2012)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
AU5016793A (en) * 1992-08-20 1994-03-15 Cytomed, Inc Dual functional anti-inflammatory and immunosuppressive agents
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
CN1308622A (zh) * 1998-05-12 2001-08-15 美国家用产品公司 用于治疗胰岛素抗性和高血糖的联苯基氧代－乙酸
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
CA2924168A1 (en) * 2013-09-13 2015-03-19 Cortendo Ab (Publ) Novel cytochrome p450 inhibitors and their method of use
CN105348182B (zh) * 2014-08-24 2018-04-13 复旦大学 2‑烷氧基苯甲酰芳胺类化合物及其药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8401486A1 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
PE26691A1 (es) 1991-10-21
BR9106433A (pt) 1993-05-04
IL98075A0 (en) 1992-06-21
ES2061247T3 (es) 1994-12-01
HU9203496D0 (en) 1993-01-28
PT97616A (pt) 1992-03-31
MA22151A1 (fr) 1991-12-31
DE69104481D1 (de) 1994-11-10
GT199100031A (es) 1992-10-30
NZ238089A (en) 1992-10-28
AU642265B2 (en) 1993-10-14
AP224A (en) 1992-10-27
AU7867191A (en) 1991-11-27
CN1057839A (zh) 1992-01-15
MY105512A (en) 1994-10-31
WO1991017163A1 (en) 1991-11-14
HUT62894A (en) 1993-06-28
BG97059A (bg) 1993-12-24
DE69104481T2 (de) 1995-02-09
EP0533695A1 (en) 1993-03-31
ATE112567T1 (de) 1994-10-15
JPH05505619A (ja) 1993-08-19
EP0533695B1 (en) 1994-10-05
CA2080476A1 (en) 1991-11-10
NO924290L (no) 1992-11-06
IE911553A1 (en) 1991-11-20
TW205549B (en, 2012) 1993-05-11
RO109450B1 (ro) 1995-02-28
JPH0678340B2 (ja) 1994-10-05
AP9100259A0 (en) 1991-07-31
FI925053A7 (fi) 1992-11-06
FI925053A0 (fi) 1992-11-06
YU81191A (sh) 1994-06-10
DK0533695T3 (da) 1995-01-09
ZA913497B (en) 1992-12-30
FI925053L (fi) 1992-11-06

Similar Documents

Publication Publication Date Title
NO894296D0 (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
NO883540L (no) Fremgangsmaate og anlegg for behandling av slam.
NO934304L (no) Fremgangsmaate for behandling av fluoralumosilikatglass
DE3854540D1 (de) Behandlungsapparat und Verfahren.
NO922275D0 (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
NZ263084A (en) Dipeptide derivatives, treatment of immunomediated inflammatory disorders
EP0649307A4 (en) METHOD FOR USING (-) - CISAPRIDE FOR TREATING GASTIC EYE ELEMENTS AND OTHER DISEASES.
NO904039D0 (no) Apparat for behandling av ledninger.
NO881322D0 (no) Fremgangsmaate og anlegg for behandling av returnert boreslam.
EP0651639A4 (en) METHODS OF USING CISAPRIDE (+) FOR THE TREATMENT OF GASTROSOPHAGIC REFLUX AND OTHER DISORDERS.
FI924869A7 (fi) Kinoliinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden terapeuttinen käyttö
NO924290D0 (no) Azabenzimidazoler for behandling av astma, artritt og lignende lidelser
NO931445D0 (no) Overflatebehandling og fremgangsmaate for tilvirkning av disse
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO883220D0 (no) Innretning og preparat for behandling av gommene.
IT1288399B1 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
NO880292D0 (no) Fremgangsmaate for behandling av humle.
DE3873848D1 (de) Behandlungsapparat und -verfahren.
NO923455L (no) Indolsulfonamidsubstituert dihydropyridin, fremgangsmaate for fremstilling og anvendelse i legemidler
DE3883878D1 (de) Behandlungsapparat und Verfahren.
NO884635D0 (no) Fremgangsmaate for behandling av most.
DK236489D0 (da) Anvendelse af diazepinoner til terapeutisk behandling af mikrokredsloebsforstyrrelser
DK291289A (da) Anvendelse af 11-substituerede 5,11-dihydro-6h-pyridooe2,3-baa-oe1,4aabenzodiazepinoner til behandling af bradycardier og bradyarrhytmier hos mennesker og dyr
NO882382D0 (no) Fremgangsmaate og apparat for behandling av vann.
NO900044D0 (no) Hemorroidale, andre blandinger og metoder for behandling.